Analysis of the effectiveness of the combination of bevacizumab and irinotecan for the treatment of glial tumors. Research, Society and Development, [S. l.], v. 11, n. 1, p. e37911125135, 2022. DOI: 10.33448/rsd-v11i1.25135. Disponível em: https://rsdjournal.org/rsd/article/view/25135. Acesso em: 5 dec. 2025.